Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk
使用离体、体内模型和患者突变来探究胰腺外分泌-内分泌串扰
基本信息
- 批准号:10594228
- 负责人:
- 金额:$ 95.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-20 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:2&apos-DeoxythymidineAcinar CellAddressAnatomyAutophagocytosisBeta CellBiological ModelsBiologyCardiovascular DiseasesCause of DeathCell CommunicationCell LineCell physiologyCell secretionCellsCellular StressCellular biologyCoculture TechniquesCommunicationCommunitiesComplementDataData SetDefectDevelopmentDiabetes MellitusDiseaseDisease ProgressionDuct (organ) structureDuctal Epithelial CellEmbryonic DevelopmentEndocrineEstersExhibitsExocrine pancreasExtracellular SpaceFunctional disorderGene MutationGenesGenetically Engineered MouseGoalsGrowthHip region structureHormonesHumanIncubatedInsulinInsulin-Dependent Diabetes MellitusIslet CellKidney FailureLabelLipaseMalignant NeoplasmsMalignant neoplasm of pancreasMetabolicModelingMolecularMorbidity - disease rateMutationOrganoidsOutcomePancreasPancreatic DiseasesPancreatitisPathogenesisPathway interactionsPatientsPhysiologyProcessPropertyReagentResearchResolutionResourcesRoleSecondary toSliceSmall RNATestingTherapeuticTissuesTransfer RNATransplantationVariantblood glucose regulationcell typecombatdiabetes riskendoplasmic reticulum stressexosomeexperimental studyextracellular vesiclesgene producthuman diseasehumanized mousein vitro Modelin vivoin vivo Modelinduced pluripotent stem cellinsightintercellular communicationisletlipid disordermutantnon-diabeticnovelparacrinerisk variantsenescencestress granuleuptake
项目摘要
PROJECT SUMMARY
Type 1 diabetes and its metabolic consequences continue to be among the most significant biomedical
challenges in the US and worldwide today. In addition to morbidities specifically related to diabetes the disease
is associated with complications such as renal failure, lipid disorders, cardiovascular disease and cancer and is
a major cause of death worldwide. Thus there is an urgent need for a better understanding of the pathogenesis
that promotes the loss of insulin-secreting beta cells to plan better therapeutics to combat the disease. Several
studies have argued that diverse cell types that make up the pancreatic niche contribute to the pathogenesis of
the disease process. Thus a better understanding of the inter-cellular communication between major cells such
as the acinar and duct cells and islet cells are warranted. We have studied the role of the mutant carboxy ester
lipase (CEL) gene, expressed in acinar cells, on its ability to be taken up by beta cells and cause defects in its
function and growth. The goal of this proposal is to discover the changes that occur when secretome from acinar
versus duct cells are incubated with human islet and β-cells. The data from these studies will generate new
hypothesis for testing that will allow a deeper interrogation of the cross-talk between human acinar, duct and
islet cells. We will address the following Aims in this proposal: Aim 1) Determine the ability of human acinar
versus human duct cells to directly impact islet cell function. We will isolate and characterize EVs, from human
induced pluripotent stem (hIPS) cell derived acinar- versus duct-lineage committed organoids, and incubate
them with human islet/β-cells and human pancreas slices to directly examine the consequences on islet cell
biology. We will also examine the EV cargo with a particular focus on fragments derived from transfer RNAs.
Aim 2) We will interrogate the ability of EVs, derived from acinar-derived organoids generated from the hiPS
cells from MODY8 patients, to directly regulate human islet-β-cell biology. The use of human organoids and
human pancreas slices will provide translational relevance of our studies. The results and datasets obtained
from these experiments will complement the efforts of the Human Islet Research Network and provide novel
resources to be shared with the larger scientific community.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Saumya Das其他文献
Saumya Das的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Saumya Das', 18)}}的其他基金
Characterization of beta-cell-specific extracellular vesicle cargo as functional biomarkers for type I DM disease
β细胞特异性细胞外囊泡货物作为 I 型 DM 疾病功能性生物标志物的表征
- 批准号:
10517890 - 财政年份:2022
- 资助金额:
$ 95.84万 - 项目类别:
Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk
使用离体、体内模型和患者突变来探究胰腺外分泌-内分泌串扰
- 批准号:
10706558 - 财政年份:2022
- 资助金额:
$ 95.84万 - 项目类别:
Characterization of beta-cell-specific extracellular vesicle cargo as functional biomarkers for type I DM disease
β细胞特异性细胞外囊泡货物作为 I 型 DM 疾病功能性生物标志物的表征
- 批准号:
10706576 - 财政年份:2022
- 资助金额:
$ 95.84万 - 项目类别:
Functional role and therapeutic targeting of exosomes and extracellular RNA biomarkers in heart failure
外泌体和细胞外 RNA 生物标志物在心力衰竭中的功能作用和治疗靶向
- 批准号:
9894484 - 财政年份:2020
- 资助金额:
$ 95.84万 - 项目类别:
Functional role and therapeutic targeting of exosomes and extracellular RNA biomarkers in heart failure
外泌体和细胞外 RNA 生物标志物在心力衰竭中的功能作用和治疗靶向
- 批准号:
10417068 - 财政年份:2020
- 资助金额:
$ 95.84万 - 项目类别:
Functional role and therapeutic targeting of exosomes and extracellular RNA biomarkers in heart failure
外泌体和细胞外 RNA 生物标志物在心力衰竭中的功能作用和治疗靶向
- 批准号:
10176560 - 财政年份:2020
- 资助金额:
$ 95.84万 - 项目类别:
Functional role and therapeutic targeting of exosomes and extracellular RNA biomarkers in heart failure
外泌体和细胞外 RNA 生物标志物在心力衰竭中的功能作用和治疗靶向
- 批准号:
10630193 - 财政年份:2020
- 资助金额:
$ 95.84万 - 项目类别:
Molecular dissection and imaging of extracellular vesicles to define their origin and targets
细胞外囊泡的分子解剖和成像以确定其起源和目标
- 批准号:
10350010 - 财政年份:2019
- 资助金额:
$ 95.84万 - 项目类别:
Molecular dissection and imaging of extracellular vesicles to define their origin and targets
细胞外囊泡的分子解剖和成像以确定其起源和目标
- 批准号:
9811730 - 财政年份:2019
- 资助金额:
$ 95.84万 - 项目类别:
Molecular dissection and imaging of extracellular vesicles to define their origin and targets
细胞外囊泡的分子解剖和成像以确定其起源和目标
- 批准号:
10018945 - 财政年份:2019
- 资助金额:
$ 95.84万 - 项目类别:
相似海外基金
ACTG240--ZIDOVUDINE VS 2,3-DIDEHYDRO-3'DEOXYTHYMIDINE IN HIV+ CHILDREN
ACTG240--齐多夫定与 2,3-二氢-3脱氧胸苷治疗 HIV 儿童
- 批准号:
6247868 - 财政年份:1997
- 资助金额:
$ 95.84万 - 项目类别:
Synthesis of Deoxythymidine Momophosphate and Glutamyldeoxy Thymidylate By Phage
噬菌体合成脱氧胸苷单磷酸和谷氨酰脱氧胸苷酸
- 批准号:
7901803 - 财政年份:1979
- 资助金额:
$ 95.84万 - 项目类别:
Standard Grant
Regulation of Deoxythymidine Kinase in Mammalian Systems
哺乳动物系统中脱氧胸苷激酶的调节
- 批准号:
6928973 - 财政年份:1969
- 资助金额:
$ 95.84万 - 项目类别:
BMY-27857 (2'3'-DIDEHYDRO-3'-DEOXYTHYMIDINE, D4T) ADMINISTERED TO HIV+ PATIENTS
BMY-27857(23-二氢-3-脱氧胸苷,D4T)用于 HIV 患者
- 批准号:
3849039 - 财政年份:
- 资助金额:
$ 95.84万 - 项目类别:
ZIDOVUDINE VS 2',3'DIDEHYDRO-3'DEOXYTHYMIDINE IN CHILDREN
齐多夫定与 2,3二氢-3脱氧胸苷在儿童中的比较
- 批准号:
3742272 - 财政年份:
- 资助金额:
$ 95.84万 - 项目类别:
BMY-27857 (2'3'-DIDEHYDRO-3'-DEOXYTHYMIDINE, D4T) ADMINISTERED TO HIV+ PATIENTS
BMY-27857(23-二氢-3-脱氧胸苷,D4T)用于 HIV 患者
- 批准号:
3785276 - 财政年份:
- 资助金额:
$ 95.84万 - 项目类别:
AZT VS 2',3' DIDEOHYDRO-3'DEOXYTHYMIDINE IN CHILDREN W/HIV INFECTION
AZT 与 2,3 二脱氢-3脱氧胸苷治疗 HIV 感染儿童的比较
- 批准号:
5220423 - 财政年份:
- 资助金额:
$ 95.84万 - 项目类别:
AZT VS 2',3' DIDEOHYDRO-3'DEOXYTHYMIDINE IN CHILDREN W/HIV INFECTION
AZT 与 2,3 二脱氢-3脱氧胸苷治疗 HIV 感染儿童的比较
- 批准号:
2481037 - 财政年份:
- 资助金额:
$ 95.84万 - 项目类别:
ZIDOVUDINE VS 2,3-DIDEHYDRO-3 DEOXYTHYMIDINE IN HIV+ CHILDREN
齐多夫定 VS 2,3-二氢-3 脱氧胸苷治疗 HIV 儿童
- 批准号:
3742165 - 财政年份:
- 资助金额:
$ 95.84万 - 项目类别:
AZT VS 2',3' DIDEOHYDRO-3'DEOXYTHYMIDINE IN CHILDREN WITH HIV INFECTION
AZT 与 2,3 二脱氢-3脱氧胸苷治疗 HIV 感染儿童的比较
- 批准号:
3742543 - 财政年份:
- 资助金额:
$ 95.84万 - 项目类别: